Molecular Targets of β-Lactam-Based Antimicrobials: Beyond the Usual Suspects
The common practice in antibacterial drug development has been to rapidly make an attempt to find ever-more stable and broad-spectrum variants for a particular antibiotic, once a drug resistance for that antibiotic is detected. We are now facing bacterial resistance toward our clinically relevant an...
Main Author: | Monika I. Konaklieva |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2014-04-01
|
Series: | Antibiotics |
Subjects: | |
Online Access: | http://www.mdpi.com/2079-6382/3/2/128 |
Similar Items
-
β-Lactams and Ureas as Cross Inhibitors of Prokaryotic Systems
by: Monika I. Konaklieva, et al.
Published: (2023-06-01) -
β-Lactam Antibiotics Renaissance
by: Wenling Qin, et al.
Published: (2014-05-01) -
Current status of β-lactam antibiotic use and characterization of β-lactam-resistant Escherichia coli from commercial farms by integrated broiler chicken operations in Korea
by: Hye-Ri Jung, et al.
Published: (2023-12-01) -
The biosynthesis of β-lactams
by: Goh, K, et al.
Published: (1993) -
Optical microscopy reveals the dynamic nature of B. pseudomallei morphology during β-lactam antimicrobial susceptibility testing
by: Heather P. McLaughlin, et al.
Published: (2020-07-01)